相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency
Andrea Keyter et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2022)
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
Andrea Keyter et al.
FRONTIERS IN PHARMACOLOGY (2020)
Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa
Andrea Keyter et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2020)
Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients' Access to Medicines
Andrea Keyter et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2020)
The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
Andrea Keyter et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System
Andrea Keyter et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2018)
The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore
Emel Mashaki Ceyhan et al.
FRONTIERS IN PHARMACOLOGY (2018)
The South African Regulatory System: Past, Present, and Future
Andrea Keyter et al.
FRONTIERS IN PHARMACOLOGY (2018)
Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the Literature
Magdalena Bujar et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making
Ronan Donelan et al.
FRONTIERS IN PHARMACOLOGY (2016)
Refining the Benefit-Risk Framework for the Assessment of Medicines: Valuing and Weighting Benefit and Risk Parameters
S. Walker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Emerging Markets and Emerging Agencies: A Comparative Study of How Key Regulatory Agencies in Asia, Latin America, the Middle East, and Africa Are Developing Regulatory Processes and Review Models for New Medicinal Products
Neil McAuslane et al.
DRUG INFORMATION JOURNAL (2009)
分享论文
